Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders

Multiple Sclerosis Journal

Volumn 19, Issue 8, 2013, Pages 1060-1067

  Kim, Sung Min ^a   Waters, Patrick ^b   Woodhall, Mark ^b   Kim, Jee Young ^c   Kim, Jee Eun ^d   Yang, Ji Won ^a   Kim, Jun Soon ^a   Sung, Jung Joon ^a   Park, Kyung Seok ^a,c   Lee, Kwang Woo ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul Medical Center   (South Korea)

Author keywords

anti aquaporin 4 antibody; multiple sclerosis; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY; METHYLPREDNISOLONE;

ADULT; ANTIBODY DETECTION; ARTICLE; ASYMPTOMATIC DISEASE; CELL ASSAY; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE SEVERITY; EARLY DIAGNOSIS; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYALGIA; MYELITIS; MYELOOPTIC NEUROPATHY; MYOTONIA; NEUROIMAGING; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; STEROID THERAPY; TREATMENT RESPONSE;

EID: 84879766222     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512472748     Document Type: Article

References (34)

1. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489 (Pubitemid 43958540)
2. Kim W, Kim SH, Kim HJ. New insights into neuromyelitis optica. J Clin Neurol. 2011 ; 7: 115-127
3. Siritho S, Nakashima I, Takahashi T, et al. AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems. Neurology. 2011 ; 77: 827-834
4. Weinshenker BG, Carroll WM. Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?. Neurology. 2011 ; 77: 812-813
5. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815 (Pubitemid 47238676)
6. Canellas AR, Gols AR, Izquierdo JR, et al. Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology. 2007 ; 49: 393-409 (Pubitemid 46951325)
7. Trebst C, Raab P, Voss EV, et al. Longitudinal extensive transverse myelitis - it's not all neuromyelitis optica. Nat Rev Neurol. 2011 ; 7: 688-698
8. McClelland CM, Van Stavern GP, Tselis AC. Leber hereditary optic neuropathy mimicking neuromyelitis optica. J Neuroophthalmol. 2011 ; 31: 265-268
9. Kitley J, Leite M, George J, et al. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler. 2012 ; 18: 271-285
10. Kruer MC, Koch TK, Bourdette DN, et al. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology. 2010 ; 74: 1473-1475
11. Jarius S, Frederikson J, Waters P, et al. Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci. 2010 ; 298: 158-162
12. Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008 ; 70: 2197-2200
13. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 ; 69: 292-302
14. Kim SM, Go MJ, Sung JJ, et al. Painful tonic spasm in neuromyelitis optica: Incidence, diagnostic utility, and clinical characteristics. Arch Neurol. 2012 ; 69: 1026-1031
15. Kim SM, Waters P, Vincent A, et al. Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica. Journal of neurology. 2011 ;:
16. Teunissen CE, Petzold A, Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009 ; 73: 1914-1922
17. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol. 2008 ; 65: 913-919 (Pubitemid 352008474)
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
19. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999 ; 46: 878-886
20. Odom JV, Bach M, Brigell M, et al. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol. 2010 ; 120: 111-119
21. Kim SM, Waters P, Vincent A, et al. Sjogren's syndrome myelopathy: Spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica. Mult Scler. 2009 ; 15: 1062-1068
22. Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009 ; 66: 630-643
23. Collongues N, Marignier R, Zephir H, et al. High-risk syndrome for neuromyelitis optica: A descriptive and comparative study. Mult Scler. 2011 ; 17: 720-724
24. Palace J, Leite MI, Nairne A, et al. Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol. 2010 ; 67: 1016-1017
25. Kleiter I, Hellwig K, Berthele A, et al. Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol. 2012 ; 69: 239-245
26. Barnett MH, Prineas JW, Buckland ME, et al. Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler. 2012 ; 18: 108-112
27. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol. 1987 ; 44: 21-23 (Pubitemid 17087606)
28. Green AJ, Cree BA. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry. 2009 ; 80: 1002-1005
29. Kim SH, Kim SM, Vincent A, et al. Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis. J Neurol. 2010 ; 257: 920-925
30. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 ; 59: 566-569 (Pubitemid 43358081)
31. Wang KC, Tsai CP, Lee CL, et al. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan. Eur Neurol. 2011 ; 65: 99-104
32. Trebst C, Raab P, Voss EV, et al. Longitudinal extensive transverse myelitis - it's not all neuromyelitis optica. Nat Rev Neurol. 2011 ; 7: 688-698
33. Uzawa A, Mori M, Muto M, et al. When is neuromyelitis optica diagnosed after disease onset?. J Neurol. 2012 ; 259: 1066-1605
34. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003 ; 2: 117-127 (Pubitemid 37443332)